Genentech’s Ocrevus Twice-Yearly, 10-Minute Subcutaneous Injection Was Non-Inferior to Intravenous Infusion and Provided Near-Complete [...]
MIDDLETON, WI., July 19, 2023 - An international consortium led by the Americas Committee for Treatment and Research in Multiple [...]
Phase III OCARINA II trial met primary and secondary endpoints Ocrevus 10-minute injection has the potential to further improve the [...]
CRANBURY, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- NeurologyLive® and the Consortium of Multiple Sclerosis Centers (CMSC) are pleased [...]
CHARLOTTESVILLE – Multiple sclerosis affects nearly a million Americans. Symptoms can include muscle spasms, stiffness, weakness, [...]
Updates and advances multiple sclerosis neurotherapuetics Moein Amin1 & Carrie M Hersh*,2 1Cleveland Clinic, Department of [...]
The Castleman Disease Collaborative Network (CDCN) is delighted to announce the launch of the ROADMAP drug repurposing tool. The [...]
Meghan Beier recently joined the Rowan Center for Behavioral Health. Rowan is a well-established psychotherapy practice focused on [...]
PDF Version New Partnership with UpScript Provides Access to Care, Delivers PoNS Devices to Doorsteps NEWTOWN, Pa., Jan. 03, 2023 [...]
FOR INSURED PATIENTS WHO ARE FACING ACCESS AND AFFORDABILITY CHALLENGES Janssen believes that access and affordability challenges [...]